Press Room

Lisbon, May 21, 2024 – Hovione has placed fourth among the best companies to work in Portugal and was again the best in the Health Sector according to Randstad´s Employer Brand Research. The research, which was published yesterday, identified the 20 best employers in Portugal. This is the ninth annual edition of Ranstad´s study, which is based on a representative sample of the Portuguese workforce. The respondents evaluate companies according to a range of different criteria, including salary and benefits, job security, work atmosphere, and career progression opportunities. Employer branding can have a significant impact on an organization's ability to attract and retain top talent and so is becoming an increasingly important part of a company a strategy to address the talent shortage challenge.  Ilda Ventura, VP of Human Resources at Hovione explains that “Our global HR strategy is built on the need to attract, retain and empower our talented team members. Therefore, our Employer Branding needs to reflect the reality of who we are, so that we don’t just attract new talent but allow current team members to flourish. It also needs to capture the positive impact that Hovione has on the world, and how our innovative work relies on the knowledge and problem solving of our team members. We continue to work on refining and improving the work we do on our EB. This too is an important reflection of our values, and our belief in continuous improvement.” This is the third successive year that has been ranked as the most attractive company to work for in the Health Sector and placed in the top five overall  This recognition comes after Hovione was recognized as a Top Employer in all four of its global sites in January 2024, becoming the first company in Macau to do so.    About Hovione Hovione is an international company with over 60 years of experience in pharmaceutical development and manufacturing operations. As a Contract Development and Manufacturing Organization (CDMO) it has a fully integrated offering of services for drug substances, drug product intermediates and drug products. The company has four FDA inspected sites in the USA, Portugal, Ireland and China and development laboratories in Lisbon, Portugal and New Jersey, USA. Hovione provides pharmaceutical customers services for the development and compliant manufacture of innovative drugs, including highly potent compounds, and customized product solutions across the entire drug life cycle. In the inhalation area, Hovione offers a complete range of services, from API, formulation development and manufacturing, capsule filling and devices.     Hovione's culture is based on innovation, quality and dependability. Hovione is a member of Rx-360, EFCG and participates actively in industry quality improvement initiatives to lead new global industry standards.  


Hovione again ranks among best employers in Portugal

May 21, 2024

The new company, which will be located in Portugal, will focus on the development of drug delivery solutions for emerging drug modalities. Cell and gene therapies represent a paradigm shift in modern medicine, offering unprecedented opportunities to address previously untreatable diseases. ViSync solutions will help address some of the manufacturing challenges caused by the complex nature of new modalities, with special focus on stabilization, cell or tissue targeting and drug payload delivery.  Lisbon, 9th May 2024 – The specialist integrated CDMO and leader in pharmaceutical spray drying and particle engineering, and iBET (Instituto de Biologia Experimental e Tecnológica), a private not-for-profit research intensive SME in the area of Biotechnology and Life Sciences, today announced the creation of ViSync Technologies, a new joint venture located in Oeiras, close to Lisbon. The newly formed company will focus on developing innovative technologies and scalable solutions to help pharmaceutical companies address formulation and manufacturing challenges in transformative cell and gene therapies. Hovione has a strong track record in industrializing new technologies and supporting Pharma Companies with their clinical and commercial volume manufacturing needs, while iBET has a strong biological background and a global reputation for its scientific knowledge of the new therapeutic modalities space, particularly cell and gene therapy.  New modalities, such as gene and cell therapies, RNA drugs and other complex biologics, are a rapidly growing segment of the pharmaceutical industry. They promise to bring breakthroughs to the treatment of a wide range of diseases and conditions, including cancer, genetic disorders, rare diseases and neurological conditions.  While this rapid growth has been driven by remarkable efficacy in addressing unmet clinical needs, the complex nature of the new modalities brings challenges, including limited drug administration options, immunogenic responses and off-target effects, issues with high dose delivery and high costs. The poor stability of these drugs is also an issue, resulting in the need for cold supply chains. ViSync will aim to develop novel technology platforms to address the unmet needs of pharmaceutical customers developing these transformative new products. “The creation of ViSync in collaboration with iBET marks an exciting new chapter in Hovione´s commitment to innovation”, said Dr Jean-Luc Herbeaux, Hovione´s CEO. “New therapeutic modalities have the potential to bring radical improvements to current standards of care and we are thrilled to partner with iBET, a world-renowned expert organization in this area, to develop technology platforms that help customers bring transformative therapies to patients worldwide. The first step will be to assemble a team who possesses the knowledge, expertise, and ingenuity needed to navigate the complexities ahead." “The establishment of ViSync in partnership with Hovione represents a pivotal moment in iBET’s dedication to pioneering research in advanced therapies,” stated Dr. Paula Alves, iBET’s CEO. “The immense promise of these new modalities is at our reach and we are delighted to join forces with Hovione, a globally recognized leader in technological industrialization and drug delivery. In this common endeavor, we will gather the scientific and technical competences and skills to support our clients and partners in delivering groundbreaking therapies to patients globally.” ViSync will develop its own lab facility in Lisbon and expects to be able to start its research and development work by the end of 2024.   About Hovione Hovione is an international company with over 60 years of experience in pharmaceutical development and manufacturing operations. As a Contract Development and Manufacturing Organization (CDMO) it has a fully integrated offering of services for drug substances, drug product intermediates and drug products. The company has four FDA inspected sites in the USA, Portugal, Ireland and China and development laboratories in Lisbon, Portugal and New Jersey, USA. Hovione provides pharmaceutical customers services for the development and compliant manufacture of innovative drugs, including highly potent compounds, and customized product solutions across the entire drug life cycle. In the inhalation area, Hovione offers a complete range of services, from API, formulation development and manufacturing, capsule filling and devices.     Hovione's culture is based on innovation, quality and dependability. Hovione is a member of Rx-360, EFCG and participates actively in industry quality improvement initiatives to lead new global industry standards.   About iBET iBET is a private non-profit institution devoted to biotechnology research, with 35 years of experience creating and transferring knowledge to the global biopharma and biotech sectors. iBET’s core expertise lies on the development of bioprocessses and analytical tools for Advanced Therapeutic Medicinal Products (ATMPs), including cell and gene therapies, vaccines, antibodies and other innovative therapeutic products. Leveraged by the emerging areas of Data Science and Translational Immunology, we offer bespoke R&D services from early-stage R&D to GMP manufacturing.  iBET’s infrastructure comprises cutting-edge laboratories, a GMP certified Analytical Services Unit, and a Late-Stage R&D and Bioproduction Unit, covering upstream and downstream process development, bioanalytical tools for critical quality attribute monitoring, to scale-up and tech transfer. iBET also hosts satellite laboratories of major pharmaceutical companies and serves as an incubation platform for start-up/spin-off companies. iBET is driven by its innovative and agile culture of continuous improvement and a strong sense of ambition, ownership and commitment in developing and delivering the best solutions to our stakeholders.  


Hovione and iBET announce the creation of ViSync Technologies, an innovative new company that will develop solutions for unmet needs in cell and gene therapy

May 09, 2024

This year’s theme for International Women in Engineering Day is #makesafetyseen to celebrate the achievements of women around the world in engineering. Hear from some of our engineers as they share their career journeys and empower others to break barriers in the healthcare field. Thank you to Ana Rafael (Principal HSE Specialist) Catarina Coelho (Senior QC Technical Specialist), and Luísa Paulo (Corporate Quality Senior Director I) for making safety seen.  Read their statements here.   “I would like to say a word to empower young girls and show them the incredible potential of women in engineering. Engineering is not just about math and science — it's about designing safer, environmentally friendly systems, collaborating, and embracing entrepreneurship. As women in engineering, we are making a profound impact on society. I proudly graduated in Chemical Engineering from the University of Coimbra, where both boys and girls were determined to leave their mark on the world. I began my career as a researcher, simulating distillation processes. However, my passion for the environment led me to shift my focus towards engineering design for biofuels and environmental treatment plants. It was then that everything fell into place — I knew I wanted to create a better world. Years later, I seized the opportunity to start my own business, dedicated to enhancing the environmental efficiency and sustainability of various industries across Europe, KSA, and Angola. This journey taught me the importance of sustainable practices and the dedication required to secure our place in the future. Today, at Hovione, I’m able to balance both of my passions: contributing to life-saving medicines and ensuring that all of us do our jobs in a safely manner. For ourselves and for the communities where we are in. For the past 8 years, I have led and managed teams and projects, guiding Hovione sites towards a better, safer and more sustainable future. I never stop learning and embracing challenges. I believe in the power of women, driving positive change and breaking barriers. Together, we can create a safer world where women in engineering thrive and shape a brighter future for all." Ana Rafael - Principal HSE Specialist Hovione Portugal    "On International Women in Engineering Day, I take this time to reflect on my journey as a woman in the engineering field. One of the most rewarding experiences in my journey was the opportunity to work as Senior Analytical Chemist at Hovione. In this role, I had the privilege of contributing to the design and implementation of innovative solutions. On this special day, let us celebrate the remarkable achievements of women engineers worldwide. Together, we are transforming the landscape of engineering, breaking down barriers and forging a path for future generations of aspiring engineers." Catarina Coelho - Senior QC Technical Specialist Hovione Portugal   "I have been working as a Chemical Engineer for 40 years and I would like to motivate the young women who love engineering to pursue their dream. At Hovione, I have always felt appreciated and encouraged by my colleagues." Luísa Paulo - Corporate Quality Senior Director I Hovione New Jersey


2023 International Women Engineering Day

Jun 23, 2023

Last week, in an effort to increase energy security in the European Region and prepare for possible disruptions of gas supplies from Russia, the European Union (EU) member states reached a political agreement on a voluntary reduction of natural gas demand by 15% this winter. To respond to this engagement, each Member State will need to define the measures it will adopt between the 1st of August 2022 and the 31st of March 2023. To reflect the individual situations of Member States, some exceptions are expected, however, at this date details are still unknown.    Although we do not expect the Hovione manufacturing operations to be affected, it is not unreasonable to expect that some of our suppliers of raw and starting materials may be impacted.  We are therefore preparing a risk mitigation plan, which includes strengthening our supply chain to reduce the impact that any disruption may have on our activity.    One option we decided to offer to our customers is to purchase raw materials early and store them closer to our manufacturing site. If you are interested in exploring this option or have questions or alternate proposals, please contact your Account Manager.    As your partner, we are committed to employing our best efforts to mitigate any serious impact that might get in the way of our delivering the products and services requested by our customers.   Thank you for your trust and collaboration through these unprecedented challenges.    Patients need us. We are In it for life.      


Approved gas reduction in the EU

Aug 08, 2022

On July 9th, 2022, the Government of the Special Administrative Region of Macau issued the Executive Order No. 115/2022 ordering all industries and commercial businesses located in Macau to suspend operations and shut down from July 11th to July 18th as an extraordinary measure to contain the spread of COVID-19 in the community. In accordance with the executive order, the majority of businesses located in Macau are obliged to shut down from 00:00 on July 11th, 2022 to 00:00 on July 23rd, 2022, including Hovione's manufacturing facility located in the territory.    Since the start of the COVID-19 epidemic, Hovione has been employing procedures and rules to reduce and minimize the impact of forced shutdowns and closures to our manufacturing facilities. Although the temporary suspension of our activities in Macau is beyond the reasonable control of Hovione and mandated by the local government, we will continue to employ all measures to reduce and mitigate the impact of such Interruption on our activities, our customers and partners.    Some of the measures employed at this facility include building up safety stocks of raw materials and finished API, advancing shipment dispatch dates to those clients facing the highest risk of disruption, leveraging bonded warehouses to allow for continued supply of materials, among others.    We commit to immediately notifying you if there are any foreseeable disruptions that may impact your product. Should you have any questions feel free to reach out to your account manager who will be happy to support you.    In the meantime, we will continue to make safe our place of work in order to continue serving our clients and our communities the best we can as we are In it for life.           About Hovione Hovione is an international company with over 60 years of experience as a Contract Development and Manufacturing Organization (CDMO) and is currently a fully integrated supplier offering services for drug substance, drug product intermediate and drug product. With four FDA inspected sites in the USA, China, Ireland, and Portugal and development laboratories in Lisbon, Portugal and New Jersey, USA, the company provides branded pharmaceutical customers services for the development and compliant manufacture of innovative drugs including highly potent compounds and customized product solutions across the entire drug life cycle. In the inhalation area, Hovione offers a complete range of and services, from API, formulation development and devices. Hovione was the first Chemical/ Pharmaceutical Company to become a Certified B Corp, is a member of Rx-360, EFCG and participates actively in industry quality improvement initiatives to lead new global industry standards.        Find more about our site, Hovione Macau          


Communication of Site Shutdown - Hovione Macau

Jul 18, 2022

Video - We are the Second Line of Defense To watch the video with subtitles, choose your language:  PT  |  CN  |  EN   English     SARS-CoV-2: What & How Question: What is a virus? Answer: A virus is not a bacteria. A virus is a microorganism that causes damage in the body by invading cells (these cells are called hosts). Unlike bacteria, all viruses cause disease.   Question: What is the difference between a virus and a bacterium? Answer: Both bacteria and viruses are microorganisms. But think of it this way: an elephant and a rat are completely different but they’re both animals. Same goes for the virus and bacteria. Additionally, one of the biggest differences between bacteria and viruses, is their size. A bacterium is the size of a large orange, in comparison to a virus which would be the size of an apple seed.   Question: How is Covid-19 transmitted? Answer: The main route of transmission is through respiratory droplets. We expel these when we sneeze, cough or even when we talk! Another common route includes touching surfaces that have the virus and then touching your face (before washing your hands). Find more in this article published in Elsevier   Question: Can a virus live on non-living surfaces? Answer: Yes. Although viruses live off of other organisms, such as animals or plants, they can be found on non-living surfaces. However, a virus cannot survive for a very long time on non-living surfaces. Find more on The New England Journal of Medicine   Question: How long does the virus last on surfaces? Answer:      Food: no evidence to suggest it spreads through food Paper: from a few minutes up to 5 days Cardboard: ~ 24 hours Wood: ~ 4 days Plastic: ~ 2/3 days Metals:  ~ 5 days Steel: ~ 2/3 days   The overall survival rate of the virus on surfaces may vary slightly according to the amount of sunlight and humidity the virus gets exposed to. Find more on The New England Journal of Medicine   Question: Will warm weather stop the outbreak of Covid-19? Answer: It is not yet known whether weather and temperature affect the spread of Covid-19. Some other viruses, like those that cause the common cold and flu, spread more during cold weather months but that does not mean it is impossible to become sick with these viruses during other months.  There is much more to learn about the transmissibility, severity, and other features associated with Covid-19 and investigations are ongoing. Find more at   Question: Can someone who has been quarantined for Covid-19 spread the illness to others? Answer: Quarantine means separating a person or group of people who have been exposed to a contagious disease but have not developed illness (symptoms) from others who have not been exposed, in order to prevent the possible spread of that disease. Quarantine is usually established for the incubation period of the communicable disease, which is the span of time during which people have developed illness after exposure. For Covid-19, the period of quarantine is 14 days from the last date of exposure because the incubation period for this virus is 2 to 14 days. Someone who has been released from Covid-19 quarantine is not considered a risk for spreading the virus to others because they have not developed illness during the incubation period. Find more at   Question: How does Covid-19 affect our cells? Answer: Covid-19 is particularly good at sticking to respiratory tissue. This means attaching to cells found mainly in the lungs. The virus does this by using its crown-like spikes which are attached to the virus’ envelope. As a result, one virus particle can attach itself to multiple cells in the body.       The easiest paths of entry for the virus are the mouth, nose and eyes. Once the virus manages to attach itself to the host cell, the host cell will take the virus particle in. The virus will then release genetic information called RNA. RNA acts as a set of instructions that tells the host cell what to do. Therefore, RNA will stop a cell from functioning normally, and instead will convert the healthy host cell into a virus making factory. Once the new virus is assembled inside the host cell, it is released into the surroundings, hence causing even further infection in the body. If our immune system is not effective at fighting the virus and stopping it from spreading onto further cells, more virus-making factories are created in our body using our cells. This eventually kills the host cell, as it is starved by the virus, causing us to have severe respiratory problems, amongst other consequences.   Question: Why do we need to use facemasks? Answer: Facemasks reduce the distance respiratory particles can travel. This means that it reduces the chances of getting infected by preventing the spread of respiratory droplets. It also acts as a filter to the air you breath in and so prevents you from inhaling the virus. Find more at   Question: How does washing our hands with soap, get rid of the virus? Answer: Soap is crucial as it contains chemicals that break down the layer of fat surrounding the coronavirus (envelope) and hence completely destroy it. Using only water doesn’t help because it doesn’t stop the virus from sticking to your hand. Watch this video to learn how soap kills the coronavirus   Question: Why should you avoid touching your face? Answer: This is because the virus can easily enter the body through the mouth, nose or even eyes. However, the virus doesn’t enter your body through the skin, as this acts as a physical barrier.  Find more at   Question: Should I take antibiotics to treat Covid-19 and are anti-bacterial products useful? Answer: Antibiotics are not designed to stop viral infections and therefore are of no use when trying to treat Covid-19. As explained above, bacteria and viruses are two very different microorganisms. This means that anti-bacterial products are not useful either, for when disinfecting surfaces from Covid-19. Instead you should use disinfectant or alcohol.   Question: Is the virus’ ability to spread affected by the climate? Answer: So far there is no scientific evidence to suggest or prove that the virus is less effective at spreading in hot or humid weather.   Question: What are the symptoms of Covid-19? Answer:  People with Covid-19 have had a wide range of symptoms reported – ranging from mild symptoms to severe illness. Symptoms may appear 2-14 days after exposure to the virus. People with these symptoms may have Covid-19: Fever or chills Cough Shortness of breath or difficulty breathing Fatigue Muscle or body aches Headache New loss of taste or smell Sore throat Congestion or runny nose Nausea or vomiting Diarrhea This list does not include all possible symptoms. CDC will continue to update this list as we learn more about Covid-19. Find more at   Question: Can someone test negative and later positive on a viral test for Covid-19? Answer:  Yes, it is possible. You may test negative if the sample was collected early in your infection and test positive later during this illness. You could also be exposed immune to Covid-19 after the test and get infected then. Even if you test negative, you still should take steps to protect yourself and others. See Testing for Current Infection for more information. Find more at   Question: If I have recovered from Covid-19, will I be immune to it? Answer: We do not know yet if people who recover from Covid-19 can get infected again. CDC and partners are investigating to determine if a person can get sick with Covid-19 more than once. Until we know more, continue to take steps to protect yourself and others. Find more at   Question: Who is at higher risk for serious illness from Covid-19? Answer: COVID-19 is a new disease and there is limited information regarding risk factors for severe disease. Based on currently available information and clinical expertise, older adults and people of any age who have serious underlying medical conditions might be at higher risk for severe illness from Covid-19. Based on what we know now, those at high-risk for severe illness from Covid-19 are: People aged 65 years and older People who live in a nursing home or long-term care facility People of all ages with underlying medical conditions, particularly if not well controlled, including: People with chronic lung disease or moderate to severe asthma People who have serious heart conditions People who are immunocompromised Many conditions can cause a person to be immunocompromised, including cancer treatment, smoking, bone marrow or organ transplantation, immune deficiencies, poorly controlled HIV or AIDS, and prolonged use of corticosteroids and other immune weakening medications People with severe obesity (body mass index [BMI] ≥40) People with diabetes People with chronic kidney disease undergoing dialysis People with liver disease Find more at   Question: What should people at higher risk of serious illness with Covid-19 do? Answer: If you are at higher risk of getting very sick from Covid-19, you should: Stock up on supplies Take everyday precautions to keep space between yourself and others When you go out in public, keep away from others who are sick Limit close contact and wash your hands often Avoid crowds, cruise travel, and non-essential travel If there is an outbreak in your community, stay home as much as possible. Watch for symptoms and emergency signs. If you get sick, stay home and call your doctor. More information on how to prepare, what to do if you get sick, and how communities and caregivers can support those at higher risk is available on People at Risk for Serious Illness from COVID-19. Find more at   Useful links httpss:// httpss:// httpss:// httpss:// httpss:// httpss:// httpss://   Relevant Information Hovione Practical Handbook - Covid-19 The Coronavirus Prevention Handbook Spanish Flu book chapter Novel Coronavirus Pneumonia Diagnosis and Treatment Plan (Provisional 6th Edition) At the time this was the best informed source on the Novel Coronavirus is probably PRC’s Novel Coronavirus Pneumonia Diagnosis and Treatment Plan (Provisional 6th Edition). This is an unofficial google translated version of the document (6th version) Report from WHO panel of international experts that just returned from a fact-finding mission to China – (25 February 2020) WHO-2019-nCoV-IPC - Water, sanitation, hygiene, and waste management for the COVID-19 virus EN - The WHO informs that in order to sanitize surface areas you can use a mixture of 0,5% of bleach (sodium hypochlorite) in water. Bleach bottles for household use indicate the concentration percentage in their labels - a bottle from Continente supermarket, for instance, indicates 5% - therefore to use this product to sanitize an area you need to dissolve it in water - one measuring cup of bleach for nine measuring cups of water will provide you with a solution containing 0,5% bleach. Be extremely careful when handling bleach with a 5% concentration. It can burn the skin. If it spills drops to the skin or eyes wash them immediately with abundant water for two minutes.  WHO-recommended Handrub Formulations   Rate of growth of COVID-19 SARS-Cov-2 Report - 30 November 2021   Hovione Crisis Response COVID-19 - Hovione Crisis Response COVID-19 Preparedness Response - Countermeasures adopted prior to Chinese New Year at the Hovione Macau plant    Stakeholders Communiqués Communication of Site Shutdown - Hovione Macau 15 July 2022 16th Stakeholder Communiqué Covid-19 11 May 2021 15th Stakeholder Communiqué Covid-19 12 March 2021 14th Stakeholder Communiqué Covid-19 5 February 2021 13th Stakeholder Communiqué Covid-19 12 January 2021 12th Stakeholder Communiqué Covid-19 7 December 2020 11th Stakeholder Communiqué Covid-19 5 November 2020 10th Stakeholder Communiqué Covid-19 8 October 2020 9th Stakeholder Communiqué - Covid-19 2 September 2020 8th Stakeholder Communiqué - Covid-19 12 August 2020 7th External Stakeholder Communiqué - Covid-19 9 July 2020 6th External Stakeholder Communiqué - Covid-19 8 June 2020 5th External Stakeholder Communiqué - Covid-19 6 May 2020 Covid-19 FAQ 20 April 2020 4th External Stakeholder Communiqué - Covid-19 3 April 2020 Covid-19 - An update from Hovione's CEO 20 March 2020 3rd External Stakeholder Communiqué - Covid-19 13 March 2020 2nd External Stakeholder Communiqué - Covid-19 12 February 2020 1st External Stakeholder Communiqué - Coronavirus 2019-NCoV 31 January 2020   Webinar   Webinar Presentation Sharing our Covid-19 experience. Seeking Feedback 14 July 2020     Service Providers and External Visitors Guidance Protocol for External Visitors   Contingency Plan - Covid-19   Videos We are the Second Line of Defense (27 April 2020) To watch the video with subtitles, choose your language:  PT  |  CN  |  EN   Message from Élie Vannier, Chairman of the Board of Directors (30 July 2020) Language: English and subtitles in Portuguese   Return From Home Rules (7 July 2020)   Message from Filipe Gaspar, Chief Technology Officer (7 April 2020) Language: Portuguese and subtitles in English     Message from Tiago Ferreira de Matos, General Counsel (31 March 2020) Language: Portuguese and subtitles in English     Guy Villax message - Washing hands (25 March 2020)     Message from Eddy Leong, Site Manager - Macao (23 March 2020) What can people do to protect themselves and others from getting the new coronavirus Source: WHO, World Health Organization   WHO: How to handwash? With soap and water Source: WHO, World Health Organization Can masks protect against the new coronavirus infection? Source: WHO, World Health Organization     Certifications     As a result of a joint effort between Hovione and Gertal, Sete Casas and Lumiar Canteens have been certified by APCER with the “Covid Safe Verified” seal. “Covid Safe” is a brand developed by APCER that certifies compliance with the new health and safety rules, in the context of the Covid-19 pandemic. This certification is the recognition of the concern of both Hovione and Gertal in complying with the rules established and providing the best safety conditions for our Team Members.     ABC Covid-19 (for schools) ABC Covid-19 initiative aims to help schools across the country in their return to classes in a practical, direct, and efficient way, by providing support to answer the various difficulties they face in their daily routines. The team is composed of trainees and is supervised by the Covid-19 prevention team at Hovione and their aim is to inform students about what are good habits to adopt and how to prevent risks while also supporting teachers and staff with up-to-date, reliable and clear information. Here you can find all the information provided in a poster format that you can distribute throughout the school. Portuguese only. Posters 01. Uso de Máscara A / Uso de Máscara 02. Uso de Máscara B  03. Retirar a Máscara 04. Regras para sair de casa 05. Recomendações 06. Proteção Covid-19 07. Lave as mãos com frequência 08. Lavagem de mãos / Lavagem de mãos 09. Lavagem de mãos com gel desinfetante 10. Como medir a temperatura 11. Medidas Gerais 12. Medidas Escolas 13. Utilização de Líxivia (1) 14. Utilização de Líxivia (2) 15. Instruções para Elevadores 16. Distanciamento Social 17. Desinfetar Superfícies     Follow us:               17-year arts student wins ABCovid contest Tomás Oliveira, aged 17, from Escola Artística António Arroio, with the video "Covid-19 simplified for morons", which explains simply and graphically why we need a mask to protect ourselves from this virus. The ABCovid contest is an initiative taken by Hovione trainees aimed at elementary and high school students. For more details visit           Português   SARS-CoV-2: O Quê & Como Pergunta: O que é um vírus? Resposta: Um vírus não é uma bactéria. Um vírus é um microrganismo que causa danos ao organismo, invadindo as células (essas células são chamadas de hospedeiros). Ao contrário das bactérias, todos os vírus causam doenças.   Pergunta: Qual é a diferença entre um vírus e uma bactéria? Resposta: Bactérias e vírus são microrganismos. Mas pense assim: um elefante e um rato são completamente diferentes, mas ambos são animais. O mesmo vale para o vírus e as bactérias. Além disso, uma das maiores diferenças entre bactérias e vírus é o seu tamanho. Uma bactéria é do tamanho de uma laranja grande, em comparação com um vírus do tamanho de uma semente de maçã.   Pergunta: Como o Covid-19 é transmitido? Resposta: A principal via de transmissão é através de gotículas respiratórias. Nós os expulsamos quando espirramos, tossimos ou mesmo quando conversamos! Outra rota comum inclui tocar em superfícies com o vírus e depois tocar em seu rosto (antes de lavar as mãos). Saiba mais neste artigo científico publicado na Elsevier   Pergunta: Um vírus pode viver em superfícies não-vivas? Resposta: Sim. Embora os vírus vivam de outros organismos, como animais ou plantas, eles podem ser encontrados em superfícies não-vivas. No entanto, um vírus não pode sobreviver por muito tempo em superfícies não-vivas. Saiba mais neste artigo publicado na The New England Journal of Medicine   Pergunta: Quanto tempo dura o vírus nas superfícies? Resposta: Comida: nenhuma evidência para sugerir que ela se espalha através da comida Papel: de alguns minutos a 5 dias Papelão: ~ 24 horas Madeira: ~ 4 dias Plástico: ~ 2/3 dias Metais: ~ 5 dias Aço: ~ 2/3 dias A taxa geral de sobrevivência do vírus nas superfícies pode variar ligeiramente de acordo com a quantidade de luz solar e umidade à qual o vírus é exposto. Saiba mais neste artigo publicado na The New England Journal of Medicine   Pergunta: O tempo quente vai parar o surto de Covid-19? Resposta: Ainda não se sabe se o clima e a temperatura afetam a propagação do Covid-19. Alguns outros vírus, como os que causam o resfriado e a gripe comuns, se espalham mais durante os meses de clima frio, mas isso não significa que é impossível ficar doente com esses vírus durante outros meses. Há muito mais para aprender sobre a transmissibilidade, a gravidade e outros recursos associados ao Covid-19 e às investigações em andamento. Saiba mais no website    Pergunta: Alguém que foi colocado em quarentena por Covid-19 pode espalhar a doença para outras pessoas? Resposta: Quarentena significa separar uma pessoa ou grupo de pessoas que foram expostas a uma doença contagiosa, mas não desenvolveram doenças (sintomas) de outras que não foram expostas, a fim de impedir a possível propagação dessa doença. A quarentena é geralmente estabelecida para o período de incubação da doença transmissível, que é o período durante o qual as pessoas desenvolvem doenças após a exposição. Para o COVID-19, o período de quarentena é de 14 dias a partir da última data de exposição, porque o período de incubação desse vírus é de 2 a 14 dias. Alguém que foi liberado da quarentena de COVID-19 não é considerado um risco de espalhar o vírus para outras pessoas porque não desenvolveram doenças durante o período de incubação. Saiba mais no website   Pergunta: Como o Covid-19 afeta as nossas células? Resposta: O Covid-19 é particularmente bom em aderir ao tecido respiratório. Isso significa anexar às células encontradas principalmente nos pulmões. O vírus faz isso usando seus picos em forma de coroa, anexados ao envelope do vírus. Como resultado, uma partícula de vírus pode se conectar a várias células do corpo. Os caminhos mais fáceis de entrada para o vírus são a boca, nariz e olhos. Uma vez que o vírus consiga se conectar à célula hospedeira, a célula hospedeira absorve a partícula do vírus. O vírus libera informações genéticas chamadas RNA. O RNA atua como um conjunto de instruções que informa à célula hospedeira o que fazer. Portanto, o RNA interrompe o funcionamento normal da célula e, em vez disso, converte a célula hospedeira saudável em uma fábrica de criação de vírus. Uma vez que o novo vírus é montado dentro da célula hospedeira, ele é liberado para o ambiente, causando ainda mais infecções no organismo. Se nosso sistema imunológico não é eficaz no combate ao vírus e impede que ele se espalhe para outras células, mais fábricas de criação de vírus são criadas em nosso corpo, usando nossas células. Isso acaba matando a célula hospedeira, pois ela sofre de fome pelo vírus, causando problemas respiratórios graves, entre outras consequências.     Pergunta: Por que precisamos usar máscaras? Resposta: As máscaras faciais reduzem a distância que as partículas respiratórias podem percorrer. Isso significa que reduz as chances de ser infectado, impedindo a propagação de gotículas respiratórias. Também atua como um filtro para o ar que você respira e impede a inalação do vírus. Saiba mais no website   Pergunta: Como lavar as mãos com sabão elimina o vírus? Resposta: O sabão é crucial, pois contém produtos químicos que quebram a camada de gordura ao redor do coronavírus (envelope) e, portanto, o destroem completamente. Usar apenas água não ajuda, pois não impede que o vírus grude na sua mão. Assista a este vídeo para saber como é que o sabão elimina o vírus   Pergunta: Por que você deve evitar tocar no seu rosto? Resposta: Isso ocorre porque o vírus pode facilmente entrar no corpo pela boca, nariz ou até olhos. No entanto, o vírus não entra no seu corpo através da pele, pois atua como uma barreira física. Saiba mais no website   Pergunta: Devo tomar antibióticos para tratar o Covid-19 e os produtos antibacterianos são úteis? Resposta: Os antibióticos não são projetados para interromper infecções virais e, portanto, não são úteis ao tentar tratar o Covid-19. Como explicado acima, bactérias e vírus são dois microorganismos muito diferentes. Isso significa que os produtos antibacterianos também não são úteis, ao desinfetar superfícies do Covid-19. Em vez disso, você deve usar desinfetante ou álcool.   Pergunta: A capacidade do vírus se espalhar é afetada pelo clima? Resposta: Até o momento, não há evidências científicas para sugerir ou provar que o vírus é menos eficaz na propagação em clima quente ou úmido.   Pergunta: Quais são os sintomas da Covid-19? Resposta: Pessoas com Covid-19 tiveram uma ampla gama de sintomas relatados - desde sintomas leves a doenças graves. Os sintomas podem aparecer 2-14 dias após a exposição ao vírus. Pessoas com esses sintomas podem ter Covid-19: Febre ou calafrios Tosse Falta de ar ou dificuldade em respirar Fadiga Dores musculares ou corporais Dor de cabeça Nova perda de paladar ou olfato Dor de garganta Congestão ou coriza Náusea ou vômito Diarreia Esta lista não inclui todos os sintomas possíveis. O CDC continuará a atualizar esta lista à medida que aprendermos mais sobre o Covid-19. Saiba mais no website   Pergunta: Alguém pode testar negativo e posteriormente positivo num teste viral para o Covid-19? Resposta: Sim, é possível. Você pode ter um resultado negativo se a amostra foi coletada no início de sua infeção e um resultado positivo mais tarde durante esta doença. Você também pode ser exposto ao Covid-19 imune após o teste e infetado. Mesmo se você testar negativo, você ainda deve tomar medidas para proteger a si e aos outros. Consulte Teste para infecção atual para obter mais informações. Saiba mais no website   Pergunta: Se eu me recuperei do Covid-19, estarei imune? Resposta: Ainda não sabemos se as pessoas que se recuperam do Covid-19 de ficar doente com Covid-19 mais de uma vez. Até que saibamos mais, continue a tomar medidas para proteger a si e aos outros. Saiba mais no website   Pergunta: Quem está em maior risco de doenças graves por causa da Covid-19? Resposta: Covid-19 é uma doença nova e há informações limitadas sobre fatores de risco para doenças graves. Com base nas informações disponíveis no momento e nos conhecimentos clínicos, idosos e pessoas de qualquer idade com sérias condições médicas subjacentes podem estar em maior risco de doença grave por causa do Covid-19. Com base no que sabemos agora, aqueles com alto risco de doença grave por Covid-19 são: Pessoas com 65 anos ou mais Pessoas que vivem em um lar de idosos ou em instituições de longa permanência Pessoas de todas as idades com condições médicas subjacentes, principalmente se não forem bem controladas, incluindo: Pessoas com doença pulmonar crônica ou asma moderada a grave Pessoas que têm problemas cardíacos graves Pessoas imunológicas   Links Úteis httpss:// httpss:// httpss:// httpss:// httpss:// httpss:// httpss://   Informação Relevante Manual Prático Colaborador Hovione - Covid-19 Manual para a Prevenção e Tratamento da Covid-19 WHO-2019-nCoV-IPC - Water, sanitation, hygiene, and waste management for the COVID-19 virus Para desinfectar as superfícies a OMS recomenda uma solução (mistura) de 0,5% de lixívia (hipoclorito de sódio) em água. As embalagens de lixívia para uso doméstico indicam a concentração em % no rótulo - num exemplo do Continente vimos a indicação de 5% - daí que para conseguir ter uma concentração para desinfetar as superfícies com esse produto a 5% é preciso diluir com mais àgua:  a uma medida de lixívia a 5% juntar 9 medidas de água para ter uma solução a 0,5%. Cuidado com a lixívia, em concentrações de 5% ou mais causa queimaduras na pele. Se pingos forem para a pele ou os olhos lave abundantemente com água durante 2 minutos.   Webinar   Apresentação Webinar Resposta a Covid-19 - Partilha de experiências. Juntos somos mais fortes 16 julho 2020   Prestadores de Serviços Prestadores de Serviços: Plano de Contingência COVID-19   Regras de Circulação em Instalações Hovione em Sete Casas e Lumiar   Videos Hovione - Messagem de Élie Vannier, Presidente do Conselho de Administração (30 de julho 2020) Legendado em Português     ABCovid: Entrevista de Santiago Sampaio no programa Curto Circuito, SIC Radical (13 de julho 2020) Saber mais sobre o Concurso Nacional ABCovid   Mensagem de Ana Cristina Guimarães, Diretora de RH Portugal (26 de junho de 2020)   Mensagem de Isabel Jonet, Banco Alimentar Contra a Fome (5 de junho 2020)   Regras de Regresso de Casa (28 de maio de 2020)   Regras de Regresso de Casa - Regra 1   Regras de Regresso de Casa - Regra 2   Regras de Regresso de Casa - Regra 3   Regras de Regresso de Casa - Regra 4 e 5   Regras de Regresso de Casa - Regra 6   Regras de Regresso de Casa - Regra 7 Regras de Regresso de Casa - Regra 8   Regras de Regresso de Casa - Regra 9   Regras de Regresso de Casa - Regra 10   Regras de Regresso de Casa - Regra 11     Histórias de Superação (1 de maio de 2020)     Somos a segunda linha de defesa (27 de abril de 2020) Video disponível com legendas em  CN  |  EN       Mensagem de Filipe Gaspar, Chief Technology Officer (7 de abril de 2020)       Mensagem de Tiago Ferreira de Matos, General Counsel (31 de março de 2020)       Mensagem de Guy Villax - Lavagem de mãos (25 de março de 2020)     Mensagem de Guy Villax a partir da fábrica de Sete Casas em Portugal (19 de março de 2020)     Medidas internas coronavírus com procedimentos à chegada aos nossos sites (6 de março de 2020)   Recomendação de medidas de proteção individual e coletiva na prevenção da infeção com COVID-19 Fonte: DGS, Direção-Geral da Saúde   Prevenção e Proteção Fonte: DGS, Direção-Geral da Saúde     O novo coronavírus - COVID-19 Fonte: DGS, Direção-Geral da Saúde       Empresas alteram produção para fabricar desinfetantes Fonte: RTP1         Certificações Em resultado de um esforço conjunto entre a Hovione e a Gertal, as Cantinas de Sete Casas e do Lumiar foram certificadas pela APCER com o selo “Covid Safe Verified”. “Covid Safe” é uma marca desenvolvida pela APCER que certifica o cumprimento das novas regras de segurança e saúde, no contexto da pandemia da Covid-19. Esta certificação é o reconhecimento da preocupação da Hovione e da Gertal em cumprir as regras estabelecidas e em proporcionar as melhores condições de segurança aos nossos Colaboradores.   Notícias / Media Inspirar à ação… para uma saúde de qualidade (ODS 3) 29 janeiro 2021   ABC Covid-19 (para escolas) A iniciativa ABC Covid-19 visa ajudar as escolas de todo o país com o regresso às aulas de uma forma prática, eficaz e direta, dando apoio para enfrentar as dificuldades encontradas no funcionamento diário.  A equipa, composta por estagiários e supervisionada pela equipa de resposta ao Covid-19 da Hovione, pretende ajudar a informar os alunos dos bons hábitos a adotar e como prevenir os riscos, mas também dar apoio aos professores e funcionários para que estes tenham acesso a informação fidedigna, atualizada e simples. Aqui pode encontrar toda a nossa informação em formato PDF para poder utilizar em forma de posters na escola. Posters 01. Uso de Máscara A / Uso de Máscara 02. Uso de Máscara B  03. Retirar a Máscara 04. Regras para sair de casa 05. Recomendações 06. Proteção Covid-19 07. Lave as mãos com frequência 08. Lavagem de mãos / Lavagem de mãos 09. Lavagem de mãos com gel desinfetante 10. Como medir a temperatura 11. Medidas Gerais 12. Medidas Escolas 13. Utilização de Líxivia (1) 14. Utilização de Líxivia (2) 15. Instruções para Elevadores 16. Distanciamento Social 17. Desinfetar Superfícies   Sabe mais em Segue-nos nas redes sociais:           Esta certificação tem a validade de 6 meses e é renovada após auditorias de acompanhamento previamente agendadas ou sem aviso prévio.        Aluno de artes de 17 anos da António Arroio vence concurso ABCovid Tomás Oliveira, de 17 anos, aluno da Escola Artística António Arroio, em Lisboa, é o vencedor do concurso ABCovid, com o vídeo “Covid-19 simplificado para totós”, em que explica de modo simples e gráfico porque precisamos de máscara para nos protegermos do novo coronavírus. O concurso ABCovide é uma iniciativa dos estagiários da Hovione dirigida a estudantes do ensino básico e secundário. Para mais informações visite a página     


Covid-19 / Coronavirus

Jul 15, 2022

The Sustainability Report 2019-2020 is published under the title “Elements of the future. For tomorrow and beyond, no matter what.”  This is the fourth Sustainability Report published by Hovione and is intended to demonstrate our accountability to our stakeholders by communicating the company's progress on Environmental, Social and Governance (ESG) topics. The Report also reflects our alignment to the United Nations Sustainable Development Goals (UN SDGs).  The report has been prepared in line with the Global Reporting Initiative Standards content and quality principles, to ensure information accuracy, clarity and reliability. These standards enable greater transparency and accountability of organizations, by enhancing global comparability and quality of information around ESG performance. The information covers all our owned manufacturing and research facilities worldwide and the data presented is global. As a company, we want to manufacture and deliver medicines of the highest quality to the patients aligned with our commitment to operating a sustainable business. We have as reference the highest standards of safety and environmental performance, staffed by an engaged and diverse workforce. Being “In it for life” means that we are committed to protecting our people, our communities, our partners and the environment around us.   Find more about Sustainability at Hovione  


Hovione releases its 4th Sustainability Report

Jul 14, 2022

Contact Us

If you would like to learn more about Hovione, kindly fill in the form below and we will be revert to you soon.